GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mymetics Corp (OTCPK:MYMX) » Definitions » Days Payable

Mymetics (Mymetics) Days Payable : 934.60 (As of Sep. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Mymetics Days Payable?

Mymetics's average Accounts Payable for the three months ended in Sep. 2023 was $0.66 Mil. Mymetics's Cost of Goods Sold for the three months ended in Sep. 2023 was $0.06 Mil. Hence, Mymetics's Days Payable for the three months ended in Sep. 2023 was 934.60.

The historical rank and industry rank for Mymetics's Days Payable or its related term are showing as below:

MYMX' s Days Payable Range Over the Past 10 Years
Min: 22.87   Med: 35.93   Max: 162.12
Current: 162.12

During the past 13 years, Mymetics's highest Days Payable was 162.12. The lowest was 22.87. And the median was 35.93.

MYMX's Days Payable is not ranked
in the Biotechnology industry.
Industry Median: 147.29 vs MYMX: 162.12

Mymetics's Days Payable increased from Sep. 2022 (28.65) to Sep. 2023 (934.60). It may suggest that Mymetics delayed paying its suppliers.


Mymetics Days Payable Historical Data

The historical data trend for Mymetics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mymetics Days Payable Chart

Mymetics Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 48.13 45.92 38.52 22.87 33.34

Mymetics Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.65 47.00 90.11 379.27 934.60

Competitive Comparison of Mymetics's Days Payable

For the Biotechnology subindustry, Mymetics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mymetics's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mymetics's Days Payable distribution charts can be found below:

* The bar in red indicates where Mymetics's Days Payable falls into.



Mymetics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Mymetics's Days Payable for the fiscal year that ended in Dec. 2022 is calculated as

Days Payable (A: Dec. 2022 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2021 ) + Accounts Payable (A: Dec. 2022 )) / count ) / Cost of Goods Sold (A: Dec. 2022 )*Days in Period
=( (0.053 + 0.226) / 2 ) / 1.527*365
=0.1395 / 1.527*365
=33.34

Mymetics's Days Payable for the quarter that ended in Sep. 2023 is calculated as:

Days Payable (Q: Sep. 2023 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2023 ) + Accounts Payable (Q: Sep. 2023 )) / count ) / Cost of Goods Sold (Q: Sep. 2023 )*Days in Period
=( (0.714 + 0.597) / 2 ) / 0.064*365 / 4
=0.6555 / 0.064*365 / 4
=934.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mymetics Days Payable Related Terms

Thank you for viewing the detailed overview of Mymetics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Mymetics (Mymetics) Business Description

Traded in Other Exchanges
N/A
Address
c/o Mymetics SA, Route de la Corniche 4, Biopole Center, Epalinges, CHE, CH-1066
Mymetics Corp is a vaccine company and is focused on the research and development of next-generation vaccines for infectious and life-disabling diseases. Its vaccine candidates in the pipeline include HIV-1/AIDS, malaria, and Covid-19, and intranasal influenza, RSV, Chikungunyaand HSV vaccine candidate programs.
Executives
Marcel B. Ruegg director C/O MYMETICS CORPORATION, ROUTE DE LA CORNICHE 4 1066, EPALINGES V8 NA
Kempers Ronald Hugo Gerard officer: President, CEO, CFO ES GRANDS CHAMPS 12, DULLY V8 1195
Christopher S Henney director 10505 ROSELLE STREET, SAN DIEGO CA 92121
Grant Pickering director, officer: President and CEO C/O VAXCYTE, INC., 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS CA 94070
Ulrich Burkhard director C/O MYMETICS CORPORATION, ROUTE DE LA CORNICHE 4 1066, EPALINGES V8 NA
Jacques Francois Martin officer: CEO 40 QUAI FULCHIRON, LYON I0 69005
Antonius Johannes Stegmann officer: CSO KONINGIN EMMAPLANTSOEN 6, RIJNSBURG P7 2231TZ
Ernest M Stern director 815 CONNECTICUT AVE, NW, SUITE 500, SEYFARTH SHAW LLP, WASHINGTON DC 20006
Thomas Staehelin director POSTFACH 2879, FROMER, SCHULTHEISS & STAEHELIN, BASEL V8 CH-4002
Sylvain Fleury officer: CSO CHEMIN DE VERDONNET 9, LAUSANNE V8 1010
Round Enterprises, Ltd. 10 percent owner C/O BACHMANN TRUST COMPANY LIMITED, FRANCES HOUSE, SIR WILLIAM PLACE, ST. PETER PORT X0 GY1 4EA
Mfc Bancorp Ltd 10 percent owner ROOM 2103 SHANGHAI MART TOWER, 2299 YAN AN ROAD WEST, CHANGNING DISTRICT, SHANGHAI F4 200336
Christian Rochet director, officer: CEO 14, RUE DE LA COLOMBIERE, NYON V8 1260
Robert Zimmer director, officer: vp corp development
Ernst Lubke director, officer: CFO 39, ROUTE D'ARZIER, ARZIER V8 CH-1273